Abstract |
Pituitary dwarfism causes short stature due to partial or complete inhibition of growth hormone (GH) secretion. Supplemental therapy with human GH (rhGH) accelerates the statural growth of patients, but there is limited information about its effects on craniofacial growth. This study describes the orthodontic treatment of 2 patients (a boy and a girl) diagnosed with pituitary dwarfism and treated with rhGH therapy. Growing children have different growth velocities depending on age and sex, and this complicates the assessment of treatment effects; therefore, we used the Z-score to evaluate changes in stature and craniofacial components. Growth in craniofacial structures and stature were both enhanced by rhGH therapy during orthodontic treatment.
|
Authors | Yoshiko Tsuboi, Takashi Yamashiro, Ryoko Ando, Teruko Takano-Yamamoto |
Journal | American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics
(Am J Orthod Dentofacial Orthop)
Vol. 133
Issue 3
Pg. 450-8
(Mar 2008)
ISSN: 1097-6752 [Electronic] United States |
PMID | 18331947
(Publication Type: Case Reports, Evaluation Study, Journal Article)
|
Chemical References |
- Recombinant Proteins
- Human Growth Hormone
|
Topics |
- Adolescent
- Body Height
- Cephalometry
(standards)
- Child
- Dwarfism, Pituitary
(complications, drug therapy)
- Female
- Human Growth Hormone
(therapeutic use)
- Humans
- Male
- Malocclusion, Angle Class I
(complications, therapy)
- Maxillofacial Development
- Orthodontics, Corrective
- Palatal Expansion Technique
- Recombinant Proteins
(therapeutic use)
- Reference Standards
|